... Complementary and Alternative Medicine andMultipleSclerosis Second Edition This page intentionally left blank Complementary and Alternative Medicine andMultipleSclerosis Second Edition ... title Alternative Medicine andMultipleSclerosis Library of Congress Cataloging-in-Publication Data Bowling, Allen C Complementary and alternative medicine andmultiplesclerosis Allen C Bowling—2nd ... Alternative medicine andmultiplesclerosis c2001 Includes bibliographical references and index ISBN-13: 978-1-932603-54-5 (pbk : alk paper) ISBN-10: 1-932603-54-9 (pbk : alk paper) Multiplesclerosis Alternative...
... acid and lysophospholipids and therefore also control levels of inflammatory mediators and cytotoxic metabolites including prostaglandins, leukotrienes, and reactive oxygen species PLA2 enzymes and ... infiltration and activation during Wallerian degeneration and axonal regeneration J Neurosci 1998, 18(17):6713-6722 Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability ... supported by grant PP1055 from the National MultipleSclerosis Society 23 References 10 11 12 13 14 15 16 17 18 19 20 Prat A, Antel J: Pathogenesis of multiplesclerosis Curr Opin Neurol 2005, 18(3):225-230...
... O’reilly EJ, Levin LI, Berger T, Ascherio A: Myelin oligodendrocyte glycoprotein antibodies andmultiplesclerosis in healthy young adults Neurology 2008, 71:1142-1146 Kuhn KA, Kulik L, Tomooka ... Therapy Vol 10 No Lundberg and Venables reported in one previous study of collagen-induced arthritis [5], though other studies have found equal binding to both citrullinated and arginine-containing ... work is often regarded as hypothesisgenerating rather than hypothesis-testing The study from Kidd and colleagues [1] falls in the former group, in that it provides more questions than answers In...
... intensity and catastrophizing in individuals with multiplesclerosisand chronic pain Int J Clin Exp Hypn Jan 2011; 59(1):45–63 Krupp LB Fatigue in multiple sclerosis: Definition, pathophysiology and ... mood and affect in multiplesclerosisMultiplesclerosis therapeutics New York: Martin Dunitz; 2003:651–89 Sadovnick AD, Eisen K, Ebers GC, Paty DW Cause of death in patients attending multiplesclerosis ... clinical course of multiple sclerosis: Results of an international survey National multiplesclerosis society (USA) advisory committee on clinical trials of new agents in multiplesclerosis Neurology...
... MULTIPLESCLEROSIS CURRENT STATUS AND STRATEGIES FOR THE FUTURE Janet E Joy and Richard B Johnston, Jr., Editors Committee on Multiple Sclerosis: Current Status and Strategies ... National MultipleSclerosis Society The views presented in this report are those of the Institute of Medicine Committee on Multiple Sclerosis: Current Status and Strategies for the Future and are ... bibliographical references and index ISBN 0-309-07285-9 (hardcover) Multiplesclerosis [DNLM: MultipleSclerosis therapy MultipleSclerosis physiopathology Research WL 360 M956378 2001] I Joy, Janet...
... and leisure IPAQ score and the BDI, and all subscales of MFIS and SF36 were performed Univariate analysis between disease severity, exercise status and the BDI and all subscales of the MFIS and ... of persons with multiple sclerosis: the possible warning signs Mult Scler 2007, 13(8):1038-1045 MultipleSclerosis Council for Clinical Practice Guidelines: Fatigue andmultiple sclerosis: evidence-based ... psychological group therapy in patients with multiplesclerosis Acta Neurol Scand 2003, 107(6):394-399 Motl RW, McAuley E, Snook EM: Physical activity andmultiple sclerosis: a meta-analysis Mult Scler...
... as an internal standard The coefficient of variation of intra- and interassay determinations for trp and kyn was below 5% Recovery of trp and kyn was determined by measuring trp and kyn in 20 μl ... marker of disease activity in multiplesclerosis Brain 1997, 120(Pt 1):1-13 Sorensen PS: Biological markers in body fluids for activity and progression in multiplesclerosis Mult Scler 1999, 5:287-290 ... Weinstock-Guttman B, Herndon RM, et al: Incidence and significance of neutralizing antibodies to interferon beta-1a in multiplesclerosisMultipleSclerosis Collaborative Research Group (MSCRG)...
... with multiplesclerosisMultiplesclerosis (Houndmills, Basingstoke, England) 2005, 11(5):602-609 Comi G, Leocani L, Rossi P, Colombo B: Physiopathology and treatment of fatigue in multiplesclerosis ... in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 1983, 33(11):1444-1452 MultipleSclerosis Council for Clinical Practice Guidelines: Fatigue andmultiple sclerosis: ... assessment of fatigue in MS? Multiplesclerosis (Houndmills, Basingstoke, England) 2005, 11(2):198-202 Jackson MF, Quaal C, Reeves MA: Effects of multiplesclerosis on occupational and career patterns...
... of soluble HLA-I and soluble HAL-II Drs Minagar and Kelley have contributed to this manuscript by recruiting and examining multiplesclerosis patients, interpretation of data and preparing the ... assay included a standard curve derived from positive and negative controls Negative controls consisted of 2% BSA and human serum, free of sHLA-I and sHLA-II Positive control standards were prepared ... realm, there is a possible alteration of sHLA-I and/ or sHLA-II levels as a reflection of disease activity in multiplesclerosis (MS) Clinical and brain magnetic resonance imaging (MRI) disease...
... expression and distinct regulation of pro- and secreted IL-16 in acute, subacute and chronic MS lesions, and in normal-appearing white matter, from brain and spinal cord of 39 patients with MS and 19 ... binding proteins in multiplesclerosis plaques Neuropath and App Neurobio 1999, 25:215-25 Gveric D, Herrera BM, Cuzner ML: Receptors and the Fibrinolytic Response in MultipleSclerosis Lesions ... BD: Axonal degeneration and progressive neurology disability in multiplesclerosis Neurotox Res 2003, 5:157-64 Lassmann H, Bruck W, Lucchinetti C: Heterogeneity of multiplesclerosis pathogenesis:...
... methods and Table S1 Acknowledgements Support from the National MultipleSclerosis Society (RG3743 and a Pediatric MS Center of Excellence Center Grant) and the Department of Defense MultipleSclerosis ... MMP-8, MMP-9, IL-12p40 and IL-23 in multiplesclerosis patients treated with interferon-beta1b Mult Scler 2010, 16:801-809 29 Minagar A, Jy W, Jimenez JJ, Alexander JS: Multiplesclerosis as a vascular ... volumes and brain atrophy in multiplesclerosis Neurology 2009, 73:504-510 27 Jorgensen B, Tsao M: Dispersion models and longitudinal data analysis Stat Med 1999, 18:2257-2270 28 Alexander JS,...
... as an internal standard The coefficient of variation of intra- and interassay determinations for trp and kyn was below 5% Recovery of trp and kyn was determined by measuring trp and kyn in 20 μl ... marker of disease activity in multiplesclerosis Brain 1997, 120(Pt 1):1-13 Sorensen PS: Biological markers in body fluids for activity and progression in multiplesclerosis Mult Scler 1999, 5:287-290 ... Weinstock-Guttman B, Herndon RM, et al: Incidence and significance of neutralizing antibodies to interferon beta-1a in multiplesclerosisMultipleSclerosis Collaborative Research Group (MSCRG)...
... Reliability and Validity The distributional properties of the PRIMUS and U-FIS were explored through descriptive statistics (mean, standard deviation, median and inter-quartile range [IQR]) and floor and ... depression in multiplesclerosis a population based perspective Neurology 2003, 61:1524-27 Montel SR, Bungener C: Coping and quality of life in one hundred and thirty five subjects with multiplesclerosis ... previous years), Expanded Disability Status Scale (EDSS) score of between and 5.5 and neurologically stable for at least 30 days prior to randomization Twiss et al Health and Quality of Life...
... and leisure IPAQ score and the BDI, and all subscales of MFIS and SF36 were performed Univariate analysis between disease severity, exercise status and the BDI and all subscales of the MFIS and ... of persons with multiple sclerosis: the possible warning signs Mult Scler 2007, 13(8):1038-1045 MultipleSclerosis Council for Clinical Practice Guidelines: Fatigue andmultiple sclerosis: evidence-based ... psychological group therapy in patients with multiplesclerosis Acta Neurol Scand 2003, 107(6):394-399 Motl RW, McAuley E, Snook EM: Physical activity andmultiple sclerosis: a meta-analysis Mult Scler...
... homocysteine (Hcy) and vitamin B12 in multiplesclerosis (MS) patients and controls Box and1 Box and whisker plot of plasma homocysteine (Hcy) and vitamin B12 in multiplesclerosis (MS) patients and controls ... anxiety and depression in multiplesclerosis outpatients Acta Neurol Scand 2007, 115:67-72 Provinciali L, Ceravolo MG, Bartolini M, Logullo F, Danni M: A multidimensional assessment of multiple sclerosis: ... homocysteine levels in multiplesclerosis Arch Neurol 1994, 51:1181 Refsum H, Nurk E, Smith AD, Ueland PM, Gjesdal CG, Bjelland I, Tverdal A, Tell GS, Nygard O, Vollset SE: The Hordaland Homocysteine...
... with multiplesclerosis J Neuroimmunol 2000, 105(2):189-94 Nelissen I, Fiten P, Vandenbroeck K, Hillert J, Olsson T, Marrosu MG, Opdenakker G: PECAM1, MPO and PRKAR1A at chromosome 17q21-q24 and ... its design and coordination and drafted the manuscript Rao SM, Leo GJ, Bernardin L, Unverzagt F: Cognitive dysfunction in multiplesclerosis I Frequency, patterns, and prediction Neurology 1991, ... collection and analysed the results FC performed the statistical analysis RN, ML, AC, VA, DP and RC partecipated to acquisition of data AQ conceived the study and partecipated in its design and coordination...
... of old and new tools for multiplesclerosis Trends Neurosci 2008, 31:645-652 Jersild C, Fog T, Hansen GS, Thomsen M, Svejgaard A, Dupont B: Histocompatibility determinants in multiple sclerosis, ... Environmental factors andmultiplesclerosis Lancet Neurol 2008, 7:268-277 Islam T, Gauderman WJ, Cozen W, Hamilton AS, Burnett ME, Mack TM: Differential twin concordance for multiplesclerosis by latitude ... infectious mononucleosis and HLA-DRB1*15 in multiplesclerosis Mult Scler 2009, 15:431-436 Alves-Leon SV, Papais-Alvarenga R, Magalhaes M, Alvarenga M, Thuler LC, Fernandez y Fernandez O: Ethnicity-dependent...
... determining the causes and treatment of multiplesclerosis Nature 1999, 399:A40-A47 Christensen T: Association of human endogenous retroviruses with multiplesclerosisand possible interactions ... in MultipleSclerosis J Immunol 2004, 172:5120-5127 Sheremata WA, Minagar A, Alexander JS, Vollmer T: The role of alpha-4 integrin in the aetiology of multiple sclerosis: current knowledge and ... cerebrospinal fluid and blood PNAS 2004, 101:2428-2433 Duddy M, Bar-Or A: B-cells in multiplesclerosis Int MS J 2006, 13:84-90 Antel J, Bar-Or A: Roles of immunoglobulins and B cells in multiple sclerosis: ...